Cargando…

Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells

The androgen receptor (AR) plays a critical role in prostate cancer (PCa) development and metastasis. Thus, blocking AR activity and its downstream signaling constitutes a major strategy for PCa treatment. Here, we report on the potent anti-PCa activity of a small-molecule imidazoacridinone, C-1311....

Descripción completa

Detalles Bibliográficos
Autores principales:	Niemira, Magdalena, Borowa-Mazgaj, Barbara, Bader, Samuel B., Moszyńska, Adrianna, Ratajewski, Marcin, Karaś, Kaja, Kwaśniewski, Mirosław, Krętowski, Adam, Mazerska, Zofia, Hammond, Ester M., Skwarska, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555468/ https://www.ncbi.nlm.nih.gov/pubmed/32825120 http://dx.doi.org/10.3390/biomedicines8090292

Ejemplares similares

The imidazoacridinone C-1311 induces p53-dependent senescence or p53-independent apoptosis and sensitizes cancer cells to radiation
por: Skwarska, Anna, et al.
Publicado: (2017)

The Role of Androgen Receptor and microRNA Interactions in Androgen-Dependent Diseases
por: Bielska, Agnieszka, et al.
Publicado: (2022)

Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311
por: Burger, A M, et al.
Publicado: (1999)

Combined anticancer therapy with imidazoacridinone analogue C‐1305 and paclitaxel in human lung and colon cancer xenografts—Modulation of tumour angiogenesis
por: Świtalska, Marta, et al.
Publicado: (2022)

Cell killing by the novel imidazoacridinone antineoplastic agent, C-1311, is inhibited at high concentrations coincident with dose-differentiated cell cycle perturbation.
por: Lamb, J., et al.
Publicado: (1996)

Enhanced Activity of P4503A4 and UGT1A10 Induced by Acridinone Derivatives C-1305 and C-1311 in MCF-7 and HCT116 Cancer Cells: Consequences for the Drugs’ Cytotoxicity, Metabolism and Cellular Response
por: Pawłowska, Monika, et al.
Publicado: (2020)

Molecular Signature of Subtypes of Non-Small-Cell Lung Cancer by Large-Scale Transcriptional Profiling: Identification of Key Modules and Genes by Weighted Gene Co-Expression Network Analysis (WGCNA)
por: Niemira, Magdalena, et al.
Publicado: (2019)

Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy
por: Chen, Jia-Feng, et al.
Publicado: (2019)

COLLABORATION AGREEMENT No. K1311
por: The European Organisation for Nuclear Research, CERN, et al.
Publicado: (2006)

Androgen regulation of the androgen receptor coregulators
por: Urbanucci, Alfonso, et al.
Publicado: (2008)

Preclinical evaluation of novel imidazoacridinone derivatives with potent activity against experimental colorectal cancer.
por: Burger, A. M., et al.
Publicado: (1996)

The Effect of Conjugation with Octaarginine, a Cell-Penetrating Peptide on Antifungal Activity of Imidazoacridinone Derivative
por: Rząd, Kamila, et al.
Publicado: (2021)

Targeting SIRT2 Sensitizes Melanoma Cells to Cisplatin via an EGFR-Dependent Mechanism
por: Karwaciak, Iwona, et al.
Publicado: (2021)

Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages—Potential Implications for Cytokine Storm Syndrome
por: Karwaciak, Iwona, et al.
Publicado: (2021)

SARS-CoV-2 Proteins Induce IFNG in Th1 Lymphocytes Generated from CD4+ Cells from Healthy, Unexposed Polish Donors
por: Sałkowska, Anna, et al.
Publicado: (2020)

Chlorpromazine, a Clinically Approved Drug, Inhibits SARS-CoV-2 Nucleocapsid-Mediated Induction of IL-6 in Human Monocytes
por: Karwaciak, Iwona, et al.
Publicado: (2022)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
por: Chen, Mengqian, et al.
Publicado: (2010)

Selective androgen receptor modulators: the future of androgen therapy?
por: Christiansen, Andrew R., et al.
Publicado: (2020)

The Role of Androgens and Androgen Receptor in Human Bladder Cancer
por: Martínez-Rojo, Elizabeth, et al.
Publicado: (2021)

Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers
por: Adar, Y, et al.
Publicado: (2012)

Photodynamic Inactivation of Candida albicans with Imidazoacridinones: Influence of Irradiance, Photosensitizer Uptake and Reactive Oxygen Species Generation
por: Taraszkiewicz, Aleksandra, et al.
Publicado: (2015)

Androgen and Anaplasia
por: Huggins, Charles
Publicado: (1947)

Androgens and the breast
por: Dimitrakakis, Constantine, et al.
Publicado: (2009)

Carmustine enhances the anticancer activity of selenite in androgen-independent prostate cancer cells
por: Thamilselvan, Vijayalakshmi, et al.
Publicado: (2012)

Androgen Receptor in Laryngeal Carcinoma: Could There Be an Androgen-Refractory Tumor?
por: Goulioumis, Anastasios K., et al.
Publicado: (2011)

The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer
por: Lillie, Elizabeth O, et al.
Publicado: (2003)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

In Vitro Androgen Bioassays as a Detection Method for Designer Androgens
por: Cooper, Elliot R., et al.
Publicado: (2013)

The Androgen Hormone-Induced Increase in Androgen Receptor Protein Expression Is Caused by the Autoinduction of the Androgen Receptor Translational Activity
por: Siciliano, Tiziana, et al.
Publicado: (2022)

The application of machine learning methods to the prediction of novel ligands for RORγ/RORγT receptors
por: Bachorz, Rafał A., et al.
Publicado: (2023)

Systematic Review of Polygenic Risk Scores for Type 1 and Type 2 Diabetes
por: Padilla-Martínez, Felipe, et al.
Publicado: (2020)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

Mutational Analysis of Androgen Receptor Gene in Two Families with Androgen Insensitivity
por: Akella, Radha Ramadevi
Publicado: (2017)

The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer
por: Eisermann, Kurtis, et al.
Publicado: (2017)

Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer
por: Culig, Zoran
Publicado: (2021)

The Role of Lipid Rafts and Membrane Androgen Receptors in Androgen’s Neurotoxic Effects
por: Fadeyibi, Oluwadarasimi, et al.
Publicado: (2022)

Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
por: Zhang, Haozhe, et al.
Publicado: (2022)

α-Trifluoromethyl Chalcones as Potent Anticancer Agents for Androgen Receptor-Independent Prostate Cancer
por: Saito, Yohei, et al.
Publicado: (2021)

Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens
por: Dart, D. A., et al.
Publicado: (2011)

Refinement of the androgen response element based on ChIP-Seq in androgen-insensitive and androgen-responsive prostate cancer cell lines
por: Wilson, Stephen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rid6g93m449v6a1tobs3s7k5tr